Skip to main content
Premium Trial:

Request an Annual Quote

Greg Schiffman, James Gibson, John Rayson

Premium
Greg Schiffman has left his various senior executive positions at Affymetrix to take on the role of senior vice president and chief financial officer at Dendreon, a Seattle-based drug developer.
 
Affymetrix said last week that Schiffman resigned, effective immediately, from his posts as executive vice president, chief financial officer, and treasurer, as well as other positions he holds at Affy subsidiaries.
 
The company said James Gibson will take over the role of principal accounting officer from his position as vice president of accounting and corporate controller. Gibson formerly served as director of finance and controller at Netflix.
 
Affy said it intends to start seeking candidates for CFO and principal financial officer immediately.
 
Before working at Affymetrix, Schiffman held vice president positions at Applied Biosystems, Hewlett Packard, and IBM.
 

 
John Rayson was recently named chairman of Med BioGene, the company said.
 
Rayson has been a director of the Canadian biotech since 2004. Rayson practiced family medicine for 27 years before joining MDS Metro Laboratory Services in 1994 as president and CEO, a position he held until 2001 when he became executive vice chairman and CEO.  
 
Rayson ended his tenure as CEO at MDS this year, although he remains executive vice chairman of that company.
 

 
Note to Readers:
This is the last issue of BioArray News to publish in 2006. The next issue of the newsletter will appear on Tuesday, Jan. 2.
 

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.